FDA Rationale for Recognition Decision: Cefiderocol
FDA Rationale for Recognition Decision: Cefiderocol
Southwind Foods, LLC Recalls Frozen Shrimp Because of Possible Health Risk
Southwind Foods, LLC of Carson, California is voluntarily recalling a limited quantity of Frozen Shrimp, due to possible radionuclide (Cesium-137)…
FDA Approves Donidalorsen as First RNA-Targeted Prophylactic Treatment for Hereditary Angioedema
The FDA approves donidalorsen, the first RNA-targeted therapy for hereditary angioedema, offering significant attack reduction and convenient administration.
Energy Department to boost critical mineral supply with $1B funding
The financial support is part of the Trump administration’s effort to reduce reliance on foreign sources of critical minerals, especially…
Study Reveals Why Some Children Still Have Asthma Attacks Even With Treatment
New research uncovers complex inflammatory pathways driving asthma flare-ups in children, highlighting the need for personalized treatment strategies.
Rationale for FDA’s Position on the Cefazolin Breakpoints for Enterobacterales
Rationale for FDA’s Position on the Cefazolin Breakpoints for Enterobacterales
Rationale for FDA’s Position on the Use of Cefazolin Breakpoints as a Surrogate for Determining Breakpoints for Oral Cephalosporins for the Treatment of Uncomplicated Urinary Tract Infections
Rationale for FDA’s Position on the Use of Cefazolin Breakpoints as a Surrogate for Determining Breakpoints for Oral Cephalosporins for…
Study: High Similarity, Efficacy Between Tocilizumab Biosimilar and Reference Product in RA
New research confirms that switching from tocilizumab to its biosimilar, Avtozma, maintains efficacy and safety in patients with rheumatoid arthritis…
FDA Rationale for Breakpoints Recognition Decision: Azithromycin and Neisseria gonorrhoeae
FDA Rationale for Breakpoints Recognition Decision: Azithromycin and Neisseria gonorrhoeae
Non-Pharmaceutical Interventions Can Disrupt Dynamics of Pneumococcal Disease
The implementation of non-pharmaceutical measures during the COVID-19 pandemic reduced transmission of Streptococcus pneumoniae, a key bacterium that causes pneumococcal…